companydata.dkcompanydata.dk

MISSIONPHARMA A/S: Financial statements 2026

CVR: 26902398

Source: annual report 2026, Danish Business Authority

01/04/2025 – 31/03/2026

MISSIONPHARMA A/S (CVR 26902398) has filed annual accounts for 2026. In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. That is an increase of 25.9% compared with the year before. The profit margin was 12.9%. Equity in the 2026 report amounted to DKK 317,751,000. The solvency ratio was 68.4%. The company had 170 employees in the financial year.

Revenue
DKK 934,465,000
Gross Profit
DKK 220,698,000
Profit/Loss
DKK 120,205,000
Equity
DKK 317,751,000
Total Assets
DKK 464,879,000
Employees
170

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026934.5M220.7M120.2M317.8M170
2025742M148M73.4M273.1M169
2024940.1M203.6M119.9M319.3M158
2023942.5M215.1M119.2M340.8M58
2022694M122.3M58M312.8M55

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like MISSIONPHARMA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2026

MISSIONPHARMA A/S updates contact informationOct 21, 2026

Contact info changed: new phone: 48163200, new email: [email protected] (October 21, 2026).

MISSIONPHARMA A/S updates contact informationSep 28, 2026

Contact info changed: new phone: 48163200, new email: [email protected] (September 28, 2026).

Jean-Marc Pierre René Leccia joins the board of MISSIONPHARMA A/SSep 24, 2026

As of September 24, 2026, Jean-Marc Pierre René Leccia has joined the board of directors of MISSIONPHARMA A/S.

Eric Pierre Jean Muris joins the board of MISSIONPHARMA A/SSep 24, 2026

As of September 24, 2026, Eric Pierre Jean Muris has joined the board of directors of MISSIONPHARMA A/S.

Jean-Marc Pierre René Leccia joins MISSIONPHARMA A/S as adm. dir.Sep 24, 2026

As of September 24, 2026, Jean-Marc Pierre René Leccia is registered as adm. dir. of MISSIONPHARMA A/S.

Nicolai Buhl Andersen steps down as adm. dir. of MISSIONPHARMA A/SSep 24, 2026

As of September 24, 2026, Nicolai Buhl Andersen has stepped down as adm. dir. of MISSIONPHARMA A/S.

Jean-Marc Pierre René Leccia leaves the board of MISSIONPHARMA A/SSep 23, 2026

As of September 23, 2026, Jean-Marc Pierre René Leccia has left the board of directors of MISSIONPHARMA A/S.

Eric Pierre Jean Muris leaves the board of MISSIONPHARMA A/SSep 23, 2026

As of September 23, 2026, Eric Pierre Jean Muris has left the board of directors of MISSIONPHARMA A/S.

MISSIONPHARMA A/S updates contact informationSep 7, 2026

Contact info changed: new phone: 48163200, new email: [email protected] (September 7, 2026).

Nicolai Buhl Andersen joins MISSIONPHARMA A/S as adm. dir.Sep 1, 2026

As of September 1, 2026, Nicolai Buhl Andersen is registered as adm. dir. of MISSIONPHARMA A/S.

About MISSIONPHARMA A/S

MISSIONPHARMA A/S is a Danish company of the type Aktieselskab based in Lynge, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jean-Marc Pierre René Leccia and Edouard Marc Marie Favreau. The board consists of Eric Pierre Jean Muris (chair), Kim Erik Ginnerup, Ilona Maureen Fischer and Jean-Marc Pierre René Leccia. The company is owned by CFAO HEALTHCARE SA. The company has 60 employees (2026). In 2026, the company reported revenue of DKK 934,465,000 and a net result of DKK 120,205,000 compared with DKK 73,402,000 the year before. Equity in the 2026 report amounted to DKK 317,751,000.

Source: annual report 2026, Danish Business Authority